Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial.

MLA

Beaulieu, Maxime, et al. “Antiviral Effect of Evusheld in COVID-19 Hospitalized Patients Infected with Pre-Omicron or Omicron Variants: A Modelling Analysis of the Randomized DisCoVeRy Trial.” The Journal of Antimicrobial Chemotherapy, vol. 79, no. 11, Nov. 2024, pp. 2887–95. EBSCOhost, https://doi.org/10.1093/jac/dkae301.

APA

Beaulieu, M., Gaymard, A., Massonnaud, C., Peiffer-Smadja, N., Bouscambert-Duchamp, M., Carcelain, G., Lingas, G., Mentré, F., Ader, F., Hites, M., Poignard, P., & Guedj, J. (2024). Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial. The Journal of Antimicrobial Chemotherapy, 79(11), 2887–2895. https://doi.org/10.1093/jac/dkae301

Chicago

Beaulieu, Maxime, Alexandre Gaymard, Clément Massonnaud, Nathan Peiffer-Smadja, Maude Bouscambert-Duchamp, Guislaine Carcelain, Guillaume Lingas, et al. 2024. “Antiviral Effect of Evusheld in COVID-19 Hospitalized Patients Infected with Pre-Omicron or Omicron Variants: A Modelling Analysis of the Randomized DisCoVeRy Trial.” The Journal of Antimicrobial Chemotherapy 79 (11): 2887–95. doi:10.1093/jac/dkae301.